SAN FRANCISCO, Sept. 8 /PRNewswire-FirstCall/ -- Sirna Therapeutics, Inc. ("Sirna") (Nasdaq: RNAI - News), a leading RNAi therapeutics company, announced today that Bharat M. Chowrira, Ph.D., J.D., VP-Legal Affairs and Chief Patent Counsel, is scheduled to participate on a panel at the BioJapan 2006 World Business Forum in Osaka, Japan, from 1:30 to 3:30 pm on Friday, September 15, 2006.
